Chugai Commits $220M Into Singapore Drug Lab Post author:Sam Post published:December 28, 2017 Post category:BioPharma The drugmaker intends to expand development of therapeutic antibodies at the lab. Source: BioSpace You Might Also Like Argenx Announces Full Exercise Of Underwriters' Option To Purchase Additional ADSs May 18, 2017 Confident Bristol-Myers to Launch 700-Patient Phase III IDO Trial for Melanoma November 6, 2017 Federal Court Overturns Gilead Sciences and Merck Patent Dispute February 19, 2018
